Bare board testing company Bioptro is expecting sales between 17 to 18 billion won in the its 2020 fiscal year thanks to a rise in demand from China, the company said on Friday.
It will be up to a 40% growth year over year for the period between April, 2020 to March 2021.
Bare board testers (BBT) are used to test flexible printed circuit boards and high density interconnection (HDI) boards. The kit is placed before surface mounters to check the electric properties of the boards.
A company spokesperson said it saw sales of around 8 billion won in the first half alone. It has semiconductor package maker Simmtech as a customer.
It is seeing more shipment of BBT for smartphone HDI to China which will allow it to post the record sales, they said. Though Huawei is in trouble due to US sanctions, other vendors Oppo, Vivo and Xiaomi will work to replace that demand, the spokesperson said.
Earlier this month, Bioptro singed a 3 billion won BBT supply deal with Youngpoong Electronics __ the latter makes flexible boards for Apple’s iPads.
Bioptro has been supplying its kits to various Apple board suppliers such as Youngpoong but has been attempting to diversify its revenue stream.
The South Korean company competes Nidec-Read and Hioki of Japan. Bioptro is supplying customized jig and offering its testers at a more competitive price.
It also competes with Yamaha, the leader BBT for flexible boards.
The BTT market is seeing demand for controllers which expands points the boards are tested at production lines. This is due to printed circuit boards becoming highly dense and integrated.
24K(K=1024) and 32K BBT kit is seeing more demand from customers. 32K BBT has a total of 32,768 test points, top to bottom.
Bioptro was founded in 2000 and is based at Yongin, Gyeonggi Province. It listed on KONEX in 2016. It posted sales of 12.8 billion won for the 2019 fiscal year.